Patents Examined by Bradon Fetterolf
  • Patent number: 7238665
    Abstract: The present invention provides a peptide marker targeting to nasopharyngeal carcinoma (NPC) cells and application thereof. The peptide binds specifically to the cell surface of NPC cells. After conjugated with liposome containing chemotherapeutic drugs, such peptides deliver chemotherapeutic drugs to the tumor cells specifically and destruct tumor cells without damaging normal tissues and organs. Furthermore, such peptide is applied as a detector in the development of NPC diagnosis kit.
    Type: Grant
    Filed: March 9, 2004
    Date of Patent: July 3, 2007
    Assignee: National Taiwan University
    Inventors: Han-Chung Wu, Chin-Tarng Lin, Tong-Young Lee